Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
Clinical trial NCT04186403 · COMPLETED
Trial details
- NCT number
- NCT04186403
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2021-09-22
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.